Your account is not claimed yet. You can sign up with ORCID to claim your account.

José Lucio-Lozada (Jose Lucio-Lozada)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Venues

International journal of molecular sciences

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro Barrios-Bernal, José Lucio-Lozada, Maritza Ramos-Ramírez, Norma Hernández-Pedro, Oscar Arrieta
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition. International journal of molecular sciences 24 (5) (2023)
Pedro Barrios-Bernal, José Lucio-Lozada, Maritza Ramos-Ramírez, Norma Hernández-Pedro, Oscar Arrieta
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition. International journal of molecular sciences 24 (5) (2023)
Enrique Caballé-Perez, Norma Hernández-Pedro, Maritza Ramos-Ramírez, Pedro Barrios-Bernal, Eunice Romero-Nuñez, José Lucio-Lozada, Santiago Avila-Ríos, Gustavo Reyes-Terán, Andrés Felipe Cardona, Oscar Arrieta
Impact of KRAS G12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Pedro Barrios-Bernal, José Lucio-Lozada, Maritza Ramos-Ramírez, Norma Hernández-Pedro, Oscar Arrieta
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition. International journal of molecular sciences 24 (5) (2023)
Pedro Barrios-Bernal, José Lucio-Lozada, Maritza Ramos-Ramírez, Norma Hernández-Pedro, Oscar Arrieta
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition. International journal of molecular sciences 24 (5) (2023)
Pedro Barrios-Bernal, Norma Hernandez-Pedro, Mario Orozco-Morales, Rubí Viedma-Rodríguez, José Lucio-Lozada, Federico Avila-Moreno, Andrés F Cardona, Rafael Rosell, Oscar Arrieta
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Emilia Núñez-Peña, Paloma Siller-Garcia, Bryan F Vaca-Cartagena, José Lucio-Lozada, Silvia Villafuerte-Manrique, Mirelle Barrera López, Fernanda Mesa-Chavez, Cynthia Villarreal Garza
Activities Performed by ASCO-Sponsored Oncology Student Interest Groups in Latin America: Assessing Members' Preferences and Leaders' Challenges. JCO global oncology 8 (2022)

José Lucio-Lozada.css-eqlu8i{font-size:small;padding-left:4px;} (Jose Lucio-Lozada)

Publication Activity (10 Years)

Top Topics

Top Venues

José Lucio-Lozada (Jose Lucio-Lozada)